The just-passed 2015 federal appropriations bill includes a message from Congress that the agency overseeing the 340B drug discount program needs do more to ensure patients are directly benefiting from the program.
This message is included in an explanatory report on appropriations for HHS, which includes the Health Resources and Services Administration...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?